Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul;67(7):821-6.
doi: 10.6061/clinics/2012(07)19.

S100B protein expression in the heart of deceased individuals by overdose: a new forensic marker?

Armando Faa  1 , Giancarlo Senes, Annalisa Locci, Pietro Pampaloni, Maria Elena Pais, Bruno Piras, Ernesto d'Aloja, Gavino Faa
Affiliations

S100B protein expression in the heart of deceased individuals by overdose: a new forensic marker?

Armando Faa et al. Clinics (Sao Paulo). 2012 Jul.

Abstract

Objective: The evaluation of S100B protein expression in the human heart and its correlation with drug-related death.

Method: Left ventricular samples were collected from 74 serial forensic autopsies (15 overdose-related deaths; 59 non-overdose-related deaths) from 2007 to 2010. Tissue sections from each sample were immunostained for S100B protein by a commercial antibody.

Results: The S100B protein was detected in the heart samples of all 15 cases of drug-related deaths; S100B immunoreactivity was mainly observed in the cytoplasm of cardiomyocytes and as globular deposits in the interstitial spaces. No reactivity or weak reactivity was found in the cardiomyocytes of the 59 subjects who died of other causes.

Conclusion: Our preliminary data show that the S100B protein accumulates in injured cardiomyocytes during drug-related sudden death. Given the near absence of S100B protein in the heart of subjects who died from causes other than drug overdose, S100B immunopositivity may be used as a new ancillary screening tool for the postmortem diagnosis of overdose-related cardiac death.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported.

Figures

Figure 1
Figure 1
S100B positivity and cause of death.
Figure 2
Figure 2
Diffuse S100B intermyocite positivity with some positivity in perivessels spaces (arrow).
Figure 3
Figure 3
S100B positivity in inter-myocytes spaces with accentuation of Schwann cells in a nerve twig X 400.
Figure 4
Figure 4
S100B positivity and type of substance.
Figure 5
Figure 5
Oedema, wavy arrangement of cardiomyocytes.
See this image and copyright information in PMC

References

    1. Hollander JE, Hollander RS. In. Goldfrank LR, ed. Goldfrank's Toxicologic Emergencies. New York: McGraw-Hill Medical Pub Division. 2002;1004-19.
    1. Hale SL, Lehmann MH, Kloner RA. Electrocardiographic abnormalities after acute administration of cocaine in the rat. Am J Cardiol. 1989;63(20):1529–30. - PubMed
    1. Hale SL, Alker KJ, Rezkalla S, Figures G, Kloner RA. Adverse effect of cocaine on cardiovascular dynamics, myocardial blood flow, and coronary artery diameter in an experimental model. :927–33. Am Hearth J. 1989;118(5 Pt 1) - PubMed
    1. Aslibekyan S, Levitan EB, Mittleman MA. Prevalent Cocaine Use and Myocardial Infarction. Am J Cardiol. 2008;102(8):966–9. - PMC - PubMed
    1. Ross GS, Bell J. Myocardial infarction associated with inappropriate use of topical cocaine as treatment for epistaxis. Am J Emerg Med. 1992;10(3):219–22. - PubMed

MeSH terms